|Articles|September 13, 2010

Research Questioned

1999-Death of Jesse Gelsinger.Jesse Gelsinger was the first known subject to die in a gene therapy trial. He was a subject in a Phase I clinical trial at the University of Pennsylvania, which later helped bring to light serious issues related to informed consent and violating exclusion criteria.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Articles

Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
September 17th 2025
Generative AI Transforms Clinical Study Report Development
September 16th 2025
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
September 16th 2025

Trending on Applied Clinical Trials Online

IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes

Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success

Generative AI Transforms Clinical Study Report Development

Managing Background Therapies in the NIMBLE Phase III Trial

Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19

© 2025 MJH Life Sciences^®

All rights reserved.